Home > NRC Library > ADAMS Public Documents

06-30726-01 582442 Rib-X Pharmaceuticals, Inc.

Accession Number: ML13323B468

Date Released: Monday, April 21, 2014

Package Contents

The following links on this page are to Adobe Portable Document Format (PDF) files. To obtain a free viewer for displaying this format, see our Plugins, Viewers, and Other Tools.

• ML13323B455 - Rib-X Pharmaceuticals, Inc., Amendment Request Ltr. Dated 10/24/2013. (2 page(s), 10/24/2013)
• ML13346A223 - Rib-X Pharmaceuticals, Inc., (Melinta Therapeutics, Inc) Telephone Conversation Record dated 12/11/13 Re: Request for Additional Information of Potential Change in Control. (2 page(s), 12/11/2013)
• ML13346A251 - Melinta Therapeutics Inc., E-mail dated 12/11/13; Request for Additional Information Concerning Application for a License Amendment, Control 582442. (2 page(s), 12/11/2013)
• ML14027A252 - Melinta Therapeutics, Inc., (f/k/a/ Rid-X Pharmaceuticals, Inc.), Deficiency Response Ltr. Dated 01/20/2014. (5 page(s), 1/20/2014)
• ML14030A597 - Melinta Therapeutics, Inc., Request for Additional Information Concerning Application for Amendment to License, Control No. 582442. (4 page(s), 1/30/2014)
• ML14041A328 - Melinta Therapeutics, Inc., Telephone Conversation Record Dated 01/28/2014, Re: Request for Additional Information. (2 page(s), 1/28/2014)
• ML14080A279 - Vatera Healthcare Partners LLC, E-mail dtd 03/20/2014, RE: Ownership, Control No. 582442. (2 page(s), 3/20/2014)
• ML14084A160 - Melinta Therapeutics, Inc., (f/k/a/ Rib-X Pharmaceuticals, Inc.) Deficiency Response Letter dated 02/28/2014. (9 page(s), 2/28/2014)
• ML14111A121 - Melinta Therapeutics, Inc,; Safety Evaluation Report dated 04/09/14. (3 page(s), 4/9/2014)
• ML14111A273 - Melinta Therapeutics, Inc., License Amendment No. 5, Control No. 582442. (2 page(s), 4/9/2014)
• ML14111A262 - Melinta Therapeutics, Inc., License Amendment, Control No. 582442. (3 page(s), 4/9/2014)